QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)

Zimmer Biomet (ZBH) Competitors

$117.29
+1.16 (+1.00%)
(As of 12/7/2023 ET)
Compare
Today's Range
$115.59
$117.59
50-Day Range
$102.72
$117.95
52-Week Range
$102.00
$149.25
Volume
1.13 million shs
Average Volume
1.53 million shs
Market Capitalization
$24.51 billion
P/E Ratio
51.90
Dividend Yield
0.82%
Price Target
$140.10

ZBH vs. STE, ALGN, SNN, EW, RMD, BNTX, WST, ICLR, CAH, and MOH

Should you be buying Zimmer Biomet stock or one of its competitors? The main competitors of Zimmer Biomet include STERIS (STE), Align Technology (ALGN), Smith & Nephew (SNN), Edwards Lifesciences (EW), ResMed (RMD), BioNTech (BNTX), West Pharmaceutical Services (WST), ICON Public (ICLR), Cardinal Health (CAH), and Molina Healthcare (MOH). These companies are all part of the "medical" sector.

Zimmer Biomet vs.

Zimmer Biomet (NYSE:ZBH) and STERIS (NYSE:STE) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, community ranking, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

In the previous week, STERIS had 2 more articles in the media than Zimmer Biomet. MarketBeat recorded 9 mentions for STERIS and 7 mentions for Zimmer Biomet. Zimmer Biomet's average media sentiment score of 0.86 beat STERIS's score of 0.60 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zimmer Biomet
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
STERIS
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Zimmer Biomet received 565 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 68.72% of users gave Zimmer Biomet an outperform vote while only 58.67% of users gave STERIS an outperform vote.

CompanyUnderperformOutperform
Zimmer BiometOutperform Votes
883
68.72%
Underperform Votes
402
31.28%
STERISOutperform Votes
318
58.67%
Underperform Votes
224
41.33%

Zimmer Biomet presently has a consensus target price of $140.10, suggesting a potential upside of 19.45%. STERIS has a consensus target price of $240.60, suggesting a potential upside of 19.11%. Given Zimmer Biomet's higher possible upside, research analysts clearly believe Zimmer Biomet is more favorable than STERIS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zimmer Biomet
2 Sell rating(s)
8 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.29
STERIS
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.8%. STERIS pays an annual dividend of $2.08 per share and has a dividend yield of 1.0%. Zimmer Biomet pays out 42.5% of its earnings in the form of a dividend. STERIS pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS is clearly the better dividend stock, given its higher yield and lower payout ratio.

STERIS has a net margin of 10.52% compared to Zimmer Biomet's net margin of 6.52%. STERIS's return on equity of 13.58% beat Zimmer Biomet's return on equity.

Company Net Margins Return on Equity Return on Assets
Zimmer Biomet6.52% 12.41% 7.18%
STERIS 10.52%13.58%7.62%

Zimmer Biomet has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, STERIS has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.

Zimmer Biomet has higher revenue and earnings than STERIS. STERIS is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zimmer Biomet$7.28B3.37$231.40M$2.2651.90
STERIS$5.23B3.82$107.03M$5.5336.53

87.5% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 92.9% of STERIS shares are owned by institutional investors. 1.0% of Zimmer Biomet shares are owned by company insiders. Comparatively, 1.0% of STERIS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

STERIS beats Zimmer Biomet on 10 of the 19 factors compared between the two stocks.


Get Zimmer Biomet News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZBH vs. The Competition

MetricZimmer BiometSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$24.51B$6.97B$4.49B$15.75B
Dividend Yield0.82%1.13%2.99%3.66%
P/E Ratio51.9027.05117.0826.21
Price / Sales3.37102.852,956.317.45
Price / Cash9.2817.5921.7415.64
Price / Book2.053.154.716.54
Net Income$231.40M$121.44M$125.18M$899.95M
7 Day Performance0.85%-1.32%2.82%4.06%
1 Month Performance10.73%10.74%6.56%11.01%
1 Year Performance-5.56%-13.74%11.02%6.80%

Zimmer Biomet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STE
STERIS
2.8233 of 5 stars
$198.55
-0.4%
$240.60
+21.2%
+8.6%$19.62B$4.96B35.9017,100Analyst Report
ALGN
Align Technology
3.2675 of 5 stars
$215.35
-1.9%
$336.60
+56.3%
+16.6%$16.49B$3.81B45.6323,165Positive News
SNN
Smith & Nephew
1.3796 of 5 stars
$25.74
-1.1%
N/A-2.4%$11.24B$5.35B0.0019,012
EW
Edwards Lifesciences
2.9097 of 5 stars
$68.85
-0.5%
$81.56
+18.5%
-3.8%$41.76B$5.38B29.4217,300Analyst Report
Insider Selling
News Coverage
RMD
ResMed
3.2143 of 5 stars
$161.05
-0.3%
$202.33
+25.6%
-24.7%$23.69B$4.22B26.1410,140Analyst Revision
News Coverage
Positive News
BNTX
BioNTech
2.2544 of 5 stars
$98.74
-1.2%
$151.46
+53.4%
-37.3%$23.47B$6.62B8.564,530
WST
West Pharmaceutical Services
2.6881 of 5 stars
$343.47
-2.1%
$381.25
+11.0%
+46.0%$25.41B$2.93B46.3513,550Dividend Announcement
Insider Selling
News Coverage
ICLR
ICON Public
2.4692 of 5 stars
$269.50
+1.1%
$272.78
+1.2%
+34.0%$22.19B$8.02B43.4741,150News Coverage
CAH
Cardinal Health
2.2941 of 5 stars
$107.14
-0.3%
$96.83
-9.6%
+33.3%$26.41B$205.01B175.6448,000
MOH
Molina Healthcare
2.4099 of 5 stars
$367.01
+0.4%
$349.82
-4.7%
+8.1%$21.40B$31.97B22.8815,000Positive News

Related Companies and Tools

This page (NYSE:ZBH) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -